172 related articles for article (PubMed ID: 35566413)
1. Olfactory Neuroblastomas: What Actually Happens in the Long-Term?
Mantsopoulos K; Koch M; Iro H; Constantinidis J
J Clin Med; 2022 Apr; 11(9):. PubMed ID: 35566413
[TBL] [Abstract][Full Text] [Related]
2. Esthesioneuroblastoma and sinonasal undifferentiated carcinoma: impact of histological grading and clinical staging on survival and prognosis.
Miyamoto RC; Gleich LL; Biddinger PW; Gluckman JL
Laryngoscope; 2000 Aug; 110(8):1262-5. PubMed ID: 10942123
[TBL] [Abstract][Full Text] [Related]
3. Long-term outcome of esthesioneuroblastoma: hyams grade predicts patient survival.
Van Gompel JJ; Giannini C; Olsen KD; Moore E; Piccirilli M; Foote RL; Buckner JC; Link MJ
J Neurol Surg B Skull Base; 2012 Oct; 73(5):331-6. PubMed ID: 24083125
[TBL] [Abstract][Full Text] [Related]
4. The Prognostic Implications of Neutrophil-to-Lymphocyte Ratio in Olfactory Neuroblastoma.
Mocharnuk J; Daniels KE; Filimonov A; North LM; Gardner PA; Wang EW; Snyderman CH
Otolaryngol Head Neck Surg; 2024 Jun; ():. PubMed ID: 38895868
[TBL] [Abstract][Full Text] [Related]
5. Prognostic utility of Hyams histological grading and Kadish-Morita staging systems for esthesioneuroblastoma outcomes.
Bell D; Saade R; Roberts D; Ow TJ; Kupferman M; DeMonte F; Hanna EY
Head Neck Pathol; 2015 Mar; 9(1):51-9. PubMed ID: 24806334
[TBL] [Abstract][Full Text] [Related]
6. Exclusively endoscopic surgical resection of esthesioneuroblastoma: A systematic review.
Spielman DB; Liebowitz A; Grewal M; Safi C; Overdevest JB; Iloreta AM; Youngerman BE; Gudis DA
World J Otorhinolaryngol Head Neck Surg; 2022 Mar; 8(1):66-72. PubMed ID: 35619935
[TBL] [Abstract][Full Text] [Related]
7. Patterns of regional and distant metastasis in esthesioneuroblastoma.
Banuchi VE; Dooley L; Lee NY; Pfister DG; McBride S; Riaz N; Bilsky MH; Ganly I; Shah JP; Kraus DH; Morris LG
Laryngoscope; 2016 Jul; 126(7):1556-61. PubMed ID: 26865537
[TBL] [Abstract][Full Text] [Related]
8. Survival outcomes for stage-matched endoscopic and open resection of olfactory neuroblastoma.
Harvey RJ; Nalavenkata S; Sacks R; Adappa ND; Palmer JN; Purkey MT; Schlosser RJ; Snyderman C; Wang EW; Woodworth BA; Smee R; Havas T; Gallagher R
Head Neck; 2017 Dec; 39(12):2425-2432. PubMed ID: 28945299
[TBL] [Abstract][Full Text] [Related]
9. Recurrent Esthesioneuroblastoma: Long-Term Outcomes of Salvage Therapy.
Ni G; Pinheiro-Neto CD; Iyoha E; Van Gompel JJ; Link MJ; Peris-Celda M; Moore EJ; Stokken JK; Gamez M; Choby G
Cancers (Basel); 2023 Feb; 15(5):. PubMed ID: 36900297
[TBL] [Abstract][Full Text] [Related]
10. Regional Recurrences and Hyams Grade in Esthesioneuroblastoma.
Ziai H; Yu E; Weinreb I; Perez-Ordonez B; Yao CMKL; Xu W; Yang D; Witterick IJ; Monteiro E; Gilbert RW; Irish JC; Gullane PJ; Goldstein DP; Ringash J; Bayley A; de Almeida JR
J Neurol Surg B Skull Base; 2021 Dec; 82(6):608-614. PubMed ID: 34745827
[No Abstract] [Full Text] [Related]
11. Endoscopic Endonasal Management of Olfactory Neuroblastoma: A Retrospective Analysis of 10 Patients with Quality-of-Life Measures.
Manthuruthil C; Lewis J; McLean C; Batra PS; Barnett SL
World Neurosurg; 2016 Jun; 90():1-5. PubMed ID: 26899467
[TBL] [Abstract][Full Text] [Related]
12. Outcomes and Quality-of-Life Measures after Endoscopic Endonasal Resection of Kadish Stage C Olfactory Neuroblastomas.
Sun Y; Huang Q; Cui S; Wang M; Zhang N; Zhang S; Yang B; Qiu E; Huang Z; Zhou B
World Neurosurg; 2021 Jul; 151():e58-e67. PubMed ID: 33798777
[TBL] [Abstract][Full Text] [Related]
13. [New system combining Hyams grading system and modified Kadish stage to evaluate the progress of esthesioneuroblastoma].
Lai YY; Lin TJ; Jiang LJ; Deng J; Zuo KJ; Zhang Y; Shi JB
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Jul; 33(7):599-602. PubMed ID: 31327194
[No Abstract] [Full Text] [Related]
14. Esthesioneuroblastoma: a Danish demographic study of 40 patients registered between 1978 and 2000.
Theilgaard SA; Buchwald C; Ingeholm P; Kornum Larsen S; Eriksen JG; Sand Hansen H
Acta Otolaryngol; 2003 Apr; 123(3):433-9. PubMed ID: 12737303
[TBL] [Abstract][Full Text] [Related]
15. Olfactory neuroblastomas: an experience of 24 years.
Tural D; Yildiz O; Selcukbiricik F; Ozturk MA; Keles Y; Oz B; Uzel O; Demir G; Mandel NM
ISRN Oncol; 2011; 2011():451086. PubMed ID: 22084732
[TBL] [Abstract][Full Text] [Related]
16. Patterns of failure and outcome in esthesioneuroblastoma.
Dias FL; Sa GM; Lima RA; Kligerman J; Leoncio MP; Freitas EQ; Soares JR; Arcuri RA
Arch Otolaryngol Head Neck Surg; 2003 Nov; 129(11):1186-92. PubMed ID: 14623748
[TBL] [Abstract][Full Text] [Related]
17. Surgical Treatment of Olfactory Neuroblastoma: Major Complication Rates, Progression Free and Overall Survival.
Wertz A; Hollon T; Marentette LJ; Sullivan SE; McHugh JB; McKean EL
J Neurol Surg B Skull Base; 2018 Apr; 79(2):151-155. PubMed ID: 29868319
[No Abstract] [Full Text] [Related]
18. Esthesioneuroblastoma - a clinicopathologic study and role of DNA topoisomerase alpha.
Sharma S; Sharma MC; Johnson MH; Lou M; Thakar A; Sarkar C
Pathol Oncol Res; 2007; 13(2):123-9. PubMed ID: 17607373
[TBL] [Abstract][Full Text] [Related]
19. Consolidating the Hyams grading system in esthesioneuroblastoma - an individual participant data meta-analysis.
Vuong HG; Ngo TNM; Dunn IF
J Neurooncol; 2021 May; 153(1):15-22. PubMed ID: 33770323
[TBL] [Abstract][Full Text] [Related]
20. [Long-term experiences in the therapy of esthesioneuroblastoma].
Koch M; Constantinidis J; Dimmler A; Strauss C; Iro H
Laryngorhinootologie; 2006 Oct; 85(10):723-30. PubMed ID: 16673299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
